Australia markets closed

Abiomed, Inc. (ABMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
272.60-4.93 (-1.78%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2020
31/03/2019
31/03/2018
31/03/2017
Total revenue
798,067
840,883
769,432
593,749
445,304
Cost of revenue
150,215
151,305
129,567
98,581
70,627
Gross profit
647,852
689,578
639,865
495,168
374,677
Operating expenses
Research development
101,326
98,759
93,503
75,297
66,386
Selling general and administrative
323,966
341,600
321,550
262,734
218,153
Total operating expenses
425,292
440,359
415,053
338,031
284,539
Operating income or loss
222,560
249,219
224,812
157,137
90,138
Total other income/expenses net
-7,797
7,606
38,548
3,300
1,205
Income before tax
214,763
256,825
263,360
160,437
91,343
Income tax expense
56,089
53,816
4,344
48,267
39,227
Income from continuing operations
158,674
203,009
259,016
112,170
52,116
Net income
158,674
203,009
259,016
112,170
52,116
Net income available to common shareholders
158,674
203,009
259,016
112,170
52,116
Basic EPS
-
4.49
5.77
2.54
1.21
Diluted EPS
-
4.43
5.61
2.45
1.17
Basic average shares
-
45,179
44,911
44,153
43,238
Diluted average shares
-
45,816
46,151
45,849
44,658
EBITDA
-
269,649
238,933
168,142
96,340